![]() |
|||||||||||||||||
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||||||||
|
![]() |
EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
Volume 10, Number 11, November 2004 Histopathologic Improvement with Lymphedema Management, Léogâne, HaitiSusan F. Wilson,* Jeannette Guarner,* Alix L. Valme,† Jacky Louis-Charles,†
Tara L. Jones,* and David G. Addiss* |
|
|
![]() |
|
Back to article | |
Figure 2. Individual histologic responses of the 27 patients with follow-up biopsy specimens who participated in a lymphedema management program for ≈1 year. Black boxes indicate histopathologic regression or improvement, gray boxes indicate histopathologic progression or worsening, white boxes indicate the absence of histopathologic changes in either biopsy specimens, and boxes with a diagonal line indicate that histopathologic changes were observed on both initial and follow-up biopsy specimens. Boxes with an X indicate insufficient data. |
|
|
|
![]() |
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
![]() |
![]() |
This page last reviewed October 15, 2004 |
![]() |
![]() |
Emerging
Infectious Diseases Journal |
![]() |